Patent · US Active

Single domain antibodies to influenza hemagglutinin A and B

US12065483B1 · kind B1 · utility

0Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 23, 2024
Grant dateAug 20, 2024
Priority date—
Expiry dateJan 23, 2044

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/569
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides single-domain antibodies having binding specificity to both influenza hemagglutinin A and B and thus being capable of neutralizing both influenza A and B viruses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.